問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number299IG301
Active

2025-04-01 - 2029-09-30

Recruiting8

ICD-10N05.9

Unspecified nephritic syndrome with unspecified morphologic changes

ICD-10N06.9

Isolated proteinuria with unspecified morphologic lesion

ICD-10N07.9

Hereditary nephropathy, not elsewhere classified with unspecified morphologic lesions

ICD-10N15.9

Renal tubulo-interstitial disease, unspecified

ICD-9583.9

Nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/06/01

Investigators and Locations

Principal Investigator 彭渝森 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chung-Yi Cheng Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 吳培甄 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ping-Chin Lai Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yi wen chiu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Junne-Ming Sung Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Guan-Hsing Chen Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Mai-Szu Wu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    20 participants

  • Global

    454 participants